Rezolute (RZLT) Interest Expenses (2011 - 2026)
Rezolute (RZLT) posted Interest Expenses of $3.4 million for Q1 2026, up 36.0% sequentially from $2.5 million in Q4 2025, and down 19.05% YoY from $4.2 million in Q1 2025.
Rezolute (RZLT) Interest Expenses (2011 - 2026) Analysis & Trends
Rezolute has reported Interest Expenses for 16 years, with the latest figure at $3.4 million in Q1 2026.
- Quarterly Interest Expenses fell 19.05% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 19.05% YoY) and the FY2025 annual result came in at $89.9 million, up 515.99% from the prior year.
- Interest Expenses rose to $3.4 million in Q1 2026 per RZLT's latest filing, from $2.5 million in the prior quarter.
- Over five years, Interest Expenses peaked at $72.7 million in Q3 2025 and troughed at $128000.0 in Q2 2023.
- A 5-year average of $7.7 million and a median of $700000.0 in 2022 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses surged 5449.13% in 2024, then slumped 86.98% in 2025.
- Over 5 years, Interest Expenses stood at $598000.0 in 2022, then tumbled by 42.14% to $346000.0 in 2023, then soared by 5449.13% to $19.2 million in 2024, then plunged by 86.98% to $2.5 million in 2025, then jumped by 36.0% to $3.4 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $3.4 million, $2.5 million, and $72.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | 3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Mar 31, 2026 | 3.40 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 72.70 Mn |
| Sep 30, 2025 | 72.70 Mn |
| Jun 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 189,000.00 |
| Mar 31, 2025 | 4.20 Mn |
| Mar 31, 2025 | 4.20 Mn |
| Dec 31, 2024 | 19.20 Mn |
| Dec 31, 2024 | 19.20 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Mar 31, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 346,000.00 |
| Dec 31, 2023 | 346,000.00 |